CTRI/2022/02/040402已完成3 期
Comparison of oral tamoxifen. versus centchromon in reducing the size of breast fibroadenoma in adolescent and middle aged ladies
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •FNAC proven breast fibroadenoma of size < 5 cm
排除标准
- •1. Past history of carcinoma breast
- •2. Family history of carcinoma breast in 1st degree relatives
- •3. History of PCOD, cervical dysplasia, and liver disease
- •4. Pregnancy and Lactating ladies
- •5. Recurrent fibroadenoma
- •6. Fibroadenoma associated with cellular atypic
- •7. Ladies planning pregnancy during the study period
- •8. BMI >35 kg/m2
- •9. Baseline endometrial thickness > 12 mm
研究者
相似试验
已完成
4 期
Comparing effectiveness of Centchroman and Tamoxifen in mastalgia: a randomised control trialCTRI/2021/01/030206AIIMS Bhubaneswar56
招募中
Unknown
Centchroman vs tamoxifen in patients with breast paiCTRI/2023/11/059992on-funded
Unknown
3 期
A clinical trial to study the effects of two drugs, Centchroman versus Tamoxifen in patients with breast pain and non-cancerous breast lumps.CTRI/2016/05/006905Intra Mural Grant from All India Institute of Medical Sciences New Delhi200
尚未招募
4 期
A study to find best medicine and its dose for the treatment of breast pain.CTRI/2018/02/012043HLL lifecare Ltd
已完成
2 期
Comparison of adding Tamoxifen or Gonadotropin to Clomiphene for induction ovulation in Polycystic Ovary Syndrome (PCOS) patients resistance to ClomiphenePolycystic Ovary Syndrome.Polycystic Ovary SyndromeIRCT138904121760N8Vice Chancellor for Research and Technology, Babol University of Medical Sciences200
